We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Blood Test Could Predict Young Adults Who Might Go On To Develop Diseases of Aging

By LabMedica International staff writers
Posted on 13 Mar 2024

Everyone ages differently and two people can often have the same chronological age, but very different biological ages. More...

The future of medicine lies in knowing in advance about how someone is aging and designing personalized interventions to delay disease and extend a person’s health span. Researchers have now identified blood markers that are indicative of healthy aging or accelerated aging processes. These markers offer insights into a person’s biological age—essentially, the rate at which their cells and organs are aging, independent of their actual date of birth. This breakthrough research illuminates the biological pathways and substances that might be foundational to the aging process, providing clues as to why aging varies among individuals. It also proposes potential targets for treatments aimed at slowing the aging process and enhancing the duration of good health. This could lead to the development of a blood test capable of determining biological age in younger adults or identifying individuals at risk of developing age-related diseases.

In the study, researchers at University of Pittsburgh (Pittsburgh, PA, USA) compared 196 older individuals, categorizing them as either healthy or rapid agers based on their performance in simple walking tests. These tests are significant as walking ability integrates cardiovascular, muscular, and neurological health, making it a strong predictor of hospitalization and mortality risk in older adults. The study was unique because it compared rapid agers, aged between 65 and 75 who struggled with these physical tasks but were chronologically younger, against healthy agers, who were 75 and older but could complete the tasks without resting. This approach allowed the researchers to focus on biological rather than chronological age, setting their study apart from others that typically compare young adults to older populations. Through metabolomic analysis of blood samples from both groups, clear differences in metabolites were found between healthy and rapid agers, suggesting that blood metabolites can reflect biological age.

The researchers then established the Healthy Aging Metabolic (HAM) Index from 25 specific metabolites. This index proved more effective in differentiating between healthy and rapid agers than other aging measures. When applied to a separate group of older adults from a study in Wisconsin, the HAM Index successfully predicted individuals' ability to walk outside for 10 minutes without stopping with about 68% accuracy. Further analysis through an artificial intelligence model helped identify three key metabolites as potential promoters of healthy aging or accelerators of rapid aging. Future investigations will explore how these metabolites and their associated molecular pathways influence the aging process, with the goal of finding interventions to slow aging. The researchers also aim to study how younger individuals' metabolomes change over time in order to create a blood test that can estimate the biological age in young adults or predict the onset of aging diseases.

“While it’s great that we can predict biological aging in older adults, what would be even more exciting is a blood test that, for example, can tell someone who’s 35 that they have a biological age more like a 45-year-old,” said Aditi Gurkar, Ph.D., assistant professor of geriatric medicine at Pitt’s School of Medicine. “That person could then think about changing aspects of their lifestyle early — whether that’s improving their sleep, diet or exercise regime — to hopefully reverse their biological age.”

Related Links:
University of Pittsburgh


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Hemoglobin Stool Test
CerTest FOB 50 + 200 One Step Combo Card Test
New
Respiratory Syncytial Virus Test
OSOM® RSV Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.